10 Downing Street, die Residenz des britischen Premierministers in London.
Mittwoch, 18.04.2018 13:05 von | Aufrufe: 155

STAAR Surgical to Report First Quarter Results on May 2, 2018

10 Downing Street, die Residenz des britischen Premierministers in London. © palinchakjr / iStock Editorial / Getty Images Plus / Getty Images http://www.gettyimages.de

PR Newswire

MONROVIA, Calif., April 18, 2018 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended March 30, 2018 on Wednesday, May 2, 2018 after the market close.

STAAR will host a conference call and webcast on Wednesday, May 2 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 4089747), please dial 855-765-5684 for domestic participants and 262-912-6252 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com.

A taped replay of the conference call (Conference ID 4089747) will be available beginning approximately one hour after the call's conclusion for seven days. This replay can be accessed by dialing 855-859-2056 for domestic callers and 404-537-3406 for international callers. An archived webcast will also be available at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or "ICL".  More than 800,000 Visian ICLs have been implanted to date.  To learn more about the ICL go to: www.discovericl.com.  STAAR has approximately 350 full-time equivalent employees and markets lenses in over 75 countries.  Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com.

CONTACT:

Investors & Media


ARIVA.DE Börsen-Geflüster

Kurse

47,82 $
-0,77%
Staar Surgical Chart

EVC Group


Brian Moore, 310-579-6199


Doug Sherk, 415-652-9100

 

Cision View original content:http://www.prnewswire.com/news-releases/staar-surgical-to-report-first-quarter-results-on-may-2-2018-300631180.html

SOURCE STAAR Surgical Company

Werbung

Mehr Nachrichten zur Staar Surgical Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News